Drug development and industrial pharmacySchizophreniaRisperidoneHumansAntipsychotic AgentsNanoparticles
Advanced nanoparticle-enabled risperidone delivery for improved therapeutic outcomes of schizophrenia management: a review.
Ashwin Kumar, Mahesha Keerikkadu, Pragathi Devanand Bangera, Akshay Shetty, Vamshi Krishna Tippavajhala, Mahalaxmi Rathnanand
Published: 202510.1080/03639045.2025.2579655
Abstract
OBJECTIVE: This review aims to evaluate the therapeutic potential of Risperidone (RSP)-loaded nanoparticles as an innovative drug delivery approach for effective schizophrenia (SZ) management and improved patient outcomes. SIGNIFICANCE: Schizophrenia…
Preview only. Read the full abstract at the source